About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Cancer Stem Cells Identified by Indian-origin Researcher

by Rajashri on September 15, 2008 at 2:34 PM
Font : A-A+

 New Cancer Stem Cells Identified by Indian-origin Researcher

A way to isolate cancer stem cells in tumors so they can target the cells and kill them has been uncovered by scientists led by an Indian-origin researcher at the OU Cancer Institute.

The discovery of new cancer stem cell marker would thus dispel any chances of cancer recurrence.

Advertisement

Led by Shrikant Anant, Ph.D., and Courtney Houchen, M.D., the scientists discovered that while there were many proteins that appeared in both regular cancer cells and stem cells, there was one particular protein that appears in stem cells.

The scientists have already begun work to use the protein as a target for a new compound that once developed would kill the stem cells and kill the cancer. Thus, by targeting the stem cells, they would be able to stop the cancer from returning.
Advertisement

Now, the researchers are focusing on adult cancer stem cells because of the major role they play in the start of cancer, the growth of cancer, the spread of cancer and the return of cancer.

Current therapies generally do not target stem cells in tumors. It enables stem cells to wait until after chemotherapy or radiation treatments to begin dividing.

According to the researchers, stem cells are often responsible for the return of cancer after treatment. The identification of the stem cell marker enables researchers to develop new therapeutics that can target these cells.

Adult stem cells work as essential building blocks in organs by replenishing dying cells and regenerating damaged tissues.

It is expected that after completing initial testing, the first phase of clinical trials will begin within 5 years led by Russell Postier, M.D. The compound, if successful in human trials, is expected to be available to the public within 10 years.

One fourth of the funding for the cancer research comes from an 800,000 pounds grant from the National Institutes of Health with remaining funds from the University of Oklahoma College of Medicine.

Source: ANI
RAS/L
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Link between Dietary Intake of Plant-based Essential Fatty Acids and Death Risk
Aspirin may be Harmful When Used for Preventing 1st Heart Attack, Stroke
Pregnancy Complications Elevated Among Symptomatic COVID-19 Women
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Stem Cells - Cord Blood Stem Cells - Fundamentals Cancer and Homeopathy Parkinsons Disease Surgical Treatment Genetics and Stem Cells Cancer Facts Cancer Bone Marrow Transplantation Tissue Engineering and Regenerative Medicine Stem Cells 

Recommended Reading
Stem Cells - Fundamentals
Encyclopedia section of medindia gives general info about Stem Cells...
Stem Cells - Cord Blood
Encyclopedia section of medindia gives general info about Cord Blood...
Bone Marrow Transplantation - Animation
Animation and slides providing graphic explanation of Bone Marrow Transplantation (BMT)/Stem Cell ....
Bone Marrow Transplantation
Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are in...
Tissue Engineering and Regenerative Medicine
This new field is an amalgamation of biology, medicine and engineering, and is believed to have mind...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use